Jonathan Wingfield, Principal Scientist at AstraZeneca, describes how acoustic mass spectrometry technology being used to screen biological targets. Filmed at ELRIG Drug Discovery 2016
We’re pleased to report a new application for the Echo Liquid Handler, with plenty of resources available if you’re interested in learning more. Serial microsampling allows scientists to use fewer animals in studies and reduce costs without compromising data quality. This is particularly useful for scientists conducting pharmacokinetics (PK) and pharmacodynamics (PD) research.
Evolution of automation has moved beyond new technology to new levels of use. “Traditionally laboratory automation is deployed to execute processes that are deemed to be optimized or production-ready,” says Chris Grimley, vice president of marketing at Labcyte (Sunnyvale, Calif.). “In these situations, researchers have a good understanding of the individual steps of the process they plan to aut...
High throughput screening (HTS) is essential in the process of finding a potential drug candidate, and automation is key for a good screen both in terms of robustness and efficiency.
This video shows the process of analyzing yeast colonies used to assemble chromosomes in the GenomeFoundry at NYU Langone Medical Center.
Gingko Bioworks launched their new laboratory last month—an automated “factory” that mass-produces genetically modified organisms.
Raising glasses of genetically modified beer, the synthetic biologists at Ginkgo Bioworks celebrated the launch of a new automated lab last month. By applying engineering principles to biology, and with the help of some nifty robotic equipment, Ginkgo has created a factory for churning out exotic lifeforms, the likes of which have never before been seen on this planet.
An interview with Krister Wennerberg, Leader of the Cancer Chemical Systems Biology research group, Institute for Molecular Medicine Finland (FIMM) on Mendelspod.com
An editorial on Drug Discovery & Development, with Labcyte CEO, Mark Fischer-Colbrie.